Bio-Rad Laboratories, Inc. (BIO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Bio-Rad Laboratories, Inc. (BIO)
Company Performance

Current Price

as of Dec 03, 2024

$332.28

P/E Ratio

N/A

Market Cap

$9.31B

Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Metrics

Overview

  • HQHercules, CA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBIO
  • Price$332.28-1.92%

Trading Information

  • Market cap$9.31B
  • Float68.40%
  • Average Daily Volume (1m)194,534
  • Average Daily Volume (3m)291,942
  • EPS-$27.28

Company

  • Revenue$2.58B
  • Rev growth (1yr)2.79%
  • Net income$653.17M
  • Gross margin54.78%
  • EBITDA margin22.08%
  • EBITDA$143.47M
  • EV$9.12B
  • EV/Revenue3.54
  • P/EN/A
  • P/S3.60
  • P/B1.24